US-based Merck has received patent approval from the Indian Patent Office for two of its upcoming drugs for dyslipidemia and obesity. The two new patented drugs are in final stages of trial and are yet to receive the Drug Controller General of India’s (DCGI) approval.
The details can be read here.
No comments:
Post a Comment